A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Mycobacterium tuberculosis Extracellular Vesicle Enrichment through Size Exclusion Chromatography

2.3K views

⸱

DOI:

10.3791/63895

⸱

May 19th, 2022

In This Article

Summary

This protocol describes size exclusion chromatography, a facile and reproducible technique for enriching Mycobacterium tuberculosis extracellular vesicles from culture supernatants.

Abstract

The role of extracellular vesicles (EVs) in the context of bacterial infection has emerged as a new avenue for understanding microbial physiology. Specifically, Mycobacterium tuberculosis (Mtb) EVs play a role in the host-pathogen interaction and response to environmental stress. Mtb EVs are also highly antigenic and show potential as vaccine components. The most common method for purifying Mtb EVs is density gradient ultracentrifugation. This process has several limitations, including low throughput, low yield, reliance on expensive equipment, technical challenges, and it can negatively impact the resulting preparation. Size exclusion chromatography (SEC) is a gentler alternative method that combats many of the limitations of ultracentrifugation. This protocol demonstrates that SEC is effective for Mtb EV enrichment and produces high-quality Mtb EV preparations of increased yield in a rapid and scalable manner. Additionally, a comparison to density gradient ultracentrifugation by quantification and qualification procedures demonstrates the benefits of SEC. While the evaluation of EV quantity (nanoparticle tracking analysis), phenotype (transmission electron microscopy), and content (Western blotting) is tailored to Mtb EVs, the workflow provided can be applied to other mycobacteria.

Introduction

Extracellular vesicle (EV) release by pathogens may be the key to unlocking new technologies to control infectious diseases1. Mycobacterium tuberculosis (Mtb) is a pathogen of high consequence, infecting approximately one-third of the world's population and claiming the lives of millions of people each year2. EV production by Mtb is well documented yet elusive in the biogenesis and varied roles (i.e., immunostimulatory, immunosuppressive, iron and nutrient acquisition) of these EVs in the context of infection3,4,5. ....

Access restricted. Please log in or start a trial to view this content.

Protocol

The Colorado State University Institutional Biosafety Committee approved the present study (19-046B). Cultivation of Mycobacterium tuberculosis and harvesting of EV-rich culture supernatants were performed by trained personnel in a high-containment laboratory. The materials were moved out of the high-containment area after a valid inactivation method was performed, confirmed, and approved by institutional biosafety policies. While replicating the protocol, if validated inactivation or sterile filtration method is not feasible, the following procedures need to be performed in a high-containment laboratory.

1. Preparation of cr....

Access restricted. Please log in or start a trial to view this content.

Results

Culture filtrate protein (CFP) from Mycobacterium tuberculosis (Mtb) was concentrated, quantified, and then 3 mg of material was applied to a size exclusion chromatography (SEC) column. The protein and particle concentrations were enumerated by BCA and NTA, respectively. Expected ranges for protein and particle recovery plus the exact values obtained for these results are reported in Table 1. Values much higher than these ranges may indicate contamination or column integrity issues. Values signi.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Mycobacterium tuberculosis extracellular vesicles are highly antigenic reservoirs, which present them as an attractive avenue for developing diagnostic tools and future vaccines4,19,20. Historically, density gradient ultracentrifugation has been used to separate Mtb EVs from other soluble, secreted material8. While this process is effective, it is also time-consuming, technically challenging, and.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We would like to acknowledge support from the College of Veterinary Medicine and Biomedical Sciences Experiential Award and College Research Council Shared Research Program to NKG and funding by ATCC (award # 2016-0550-0002) to KMD. We would also like to acknowledge Anne Simpson for technical support and BEI Resources, NIAID, NIH for the following reagents: Monoclonal Anti-Mycobacterium tuberculosis LpqH (Gene Rv3763), IT-54 (produced in vitro), NR-13792, Monoclonal Anti-Mycobacterium tuberculosis GroES (Gene Rv3418c), Clone IT-3 (SA-12) (produced in vitro), NR-49223, and Monoclonal Anti-Mycobacterium tuberculosis LAM, Clone CS-35 (produced in vitro), NR-13811.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
20x MES SDS Running BufferThermoFisher ScientificNP0002
96 well plateCorning15705-066
Automatic Fraction CollectorIZON ScienceAFC-V1-USD
BenchMark Pre-stained Protein LadderInvitrogen10748010
Benchtop centrifugeBeckman CoulterAllegra 6R
Centricon Plus - 70 Centrifugal filter, 100 kDa cutoffMillipore SigmaUFC710008Ultrafiltration device used in step 1.1
Electroblotting SystemThermoFisher Scientific09-528-135
EM Grade ParaformaldehydeElectron Microscopy Sciences15714-S
Formvar/Carbon 200 mesh Cu GridsElectron Microscopy SciencesFCF200H-Cu-TA
Goat Anti-Mouse IgG H&L (Alkaline Phosphatase), whole molecule, 1 mLAbCamab6790Secondary antibody
JEM-1400 Transmission Electron MicroscopeJOEL
Micro BCA Protein Assay KitThermoFisher Scientific23235
Microplate readerBIOTEKEpoch
Monoclonal Anti-Mycobacterium tuberculosis GroES (Gene Rv3814c)BEI ResourcesNR-49223Primary antibody
Monoclonal Anti-Mycobacterium tuberculosis LpqH (Gene Rv3763)BEI ResourcesNR-13792Primary antibody
Monocolonal Anti-Mycobacterium tuberculosis LAM, Clone CS-35BEI ResourcesNR-13811Primary antibody
NanoClean 1070Fischione InstrumentsFor plasma cleaning of the TEM grid
Nanosight equipped with syringe pump and computer with NanoSight NTA softwareMalvern PanalyticalNS300
Nitrocellulose membrane, Roll, 0.2 μmBioRad1620112
NuPAGE 4-12% Bis-Tris Protein GelsThermoFisher ScientificNP0323BOX
Phosphate-buffered Saline, 1X without calcium and magnesiumCorning21-040-CV
Pierce BCA Protein Assay KitThermoFisher Scientific23225
PowerPac Basic Power SupplyBioRad1645050
qEV Original 35 nm 5/pkIZON ScienceSP5-USDSEC column
SDS sample bufferBosterAR1112In-house recipe used in this procedure, however this product is equivalent
SDS-PAGE gel chamberThermoFisher ScientificEI0001
Sigmafast BCIP/NBTMillipore SigmaB5655
Silver Stain Plus KitBioRad1610449In-house protocol used in this procedure, however this kit is equivalent
Uranyl AcetateElectron Microscopy Sciences22400

References

  1. Gill, S., Catchpole, R., Forterre, P. Extracellular membrane vesicles in the three domains of life and beyond. FEMS Microbiology Reviews. 43 (3), 273-303 (2019).
  2. World Health Organization. GLOBAL TUBERCULOSIS REPORT 2021. World Health Organization. , (2021).
  3. Prados-R....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Mycobacterium Tuberculosis EVsExtracellular VesiclesDensity Gradient UltracentrifugationNanoparticle Tracking AnalysisTransmission Electron MicroscopyWestern BlotProtein QuantificationSDS-PAGEHost Pathogen Interaction